Skip to main content
SpringerLink
Log in

Vascular endothelium in ischemic heart disease: Possible role for endothelium-derived relaxing factor

  • Angina Pectoris and Ischemic Heart Disease
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The nature, mechanism of action, and roles of endothelium-derived relaxant factor (EDRF) are reviewed, particularly in relation to the coordination of vascular behavior in response to changes in flow, coronary spasm, and platelet aggregation.

Vascular endothelium performs a multiplicity of roles. It is an active sieve for macromolecules and leukocytes, a negatively charged “lubricant” for passage of negatively charged red cells and platelets, and a factory for Von Willebrand factor, glycoaminoglycans, and plasminogen activator and its inhibitor. It is also a processing plant that metabolizes adenosine nucleotides to adenosine and activates angiotensin. Endothelium also produces prostacyclin and endothelium-derived relaxant factor, which act synergistically and through different pathways to the common ends of relaxing vascular smooth muscle and inhibiting platelet aggregation. Most recently it has been shown to also produce a constrictor agent called endothelin, a peptide whose structure has now been elucidated [1]. This review will concentrate on EDRF, the recently discovered vasodilator agent that is continuously released by all vascular endothelium [2, 3]. It would be premature to define the role of EDRF in ischemic heart disease. It may, however, be timely to consider the ways in which EDRF might be relevant, based on a review of what is at present known.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yamagisawa M, Kurihara J, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:441–445.

    Google Scholar 

  2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373–376.

    Google Scholar 

  3. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res 1983;53:557–573.

    Google Scholar 

  4. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: The basis for the proposal that acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM, ed. Mechanisms of vasodilatation, Vol IV. New York: Raven Press, in press.

  5. IgnarroL J, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide. Circ Res 1987;61:866–879.

    Google Scholar 

  6. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:526–542.

    Google Scholar 

  7. Shikano K, Ohlstein EH, Berkovitz BA. Differential selectivity of endothlium-derived relaxing factor and nitric oxide in smooth muscle. Br J Pharmacol 1987;92:483–485.

    Google Scholar 

  8. Long C, Shikano K, Berkowitz BA. Differences in the interaction of EDRF and nitric oxide with ion exchange resins. Br J Pharmacol, in press.

  9. Martin W, Smith JA, Lewis MJ, Henderson AH. Evidence that inhibitory factor extracted from bovine retractor penis is nitrite, whose acid activated derivative is stabilized nitric oxide. Br J Pharmacol, in press.

  10. Dusting GJ, Read MA, Stewart AG. Differential bioassay of endothelium-derived relaxing factor and nitric oxide on rabbit aorta and guinea-pig trachea. Br J Pharmacol, in press.

  11. Griffith TM, Edwards DH, Lewis MJ, Newby AC, Henderson AH. The nature of endothelium derived vascular relaxant factor. Nature 1984;308:645–647.

    Google Scholar 

  12. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454–456.

    Google Scholar 

  13. Rubanyi GM, Vanhoutte PM. Superoxide and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-H827.

    Google Scholar 

  14. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by haemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232:708–716.

    Google Scholar 

  15. Angus JA, Campbell GR, Cocks TM, Manderson JA. Vasodilatation by acetylcholine is endothelium-dependent: A study of sonomicrometry in canine femoral artery in vivo. J Physiol (Lond) 1983;344:209–222.

    Google Scholar 

  16. Edwards DH, Griffith TM, Ryley JC, Henderson AH. Haptglobin-haemoglobin complex in human plasma inhibits endothelium-dependent relaxation: Evidence that endothelium derived relaxing factor acts as a local autocoid. Cardiovasc Res 1986;20:549–556.

    Google Scholar 

  17. DeMey JG, Gray SD. Endothelium-dependent reactivity in resistance vessels. Prog Appl Microcirc 1985;8:181–187.

    Google Scholar 

  18. Miller VM, Vanhoutte PM. Endothelium-dependent response in isolated blood vessels of lower vertebrates. Blood Vessels 1986;23:225–235.

    Google Scholar 

  19. Thom S, Hughes A, Martin S, Sever PS. Endothelium-dependent relaxation in isolated human arteries and veins. Clin Sci 1987;73:547–552.

    Google Scholar 

  20. Griffith TM, Henderson AH, Hughes Edwards D, Lewis MJ. Isolated perfused rabbit coronary artery and aortic strip preparations; the role of endothelium-derived relaxant factor. J Physiol (Lond) 1984;351:13–24.

    Google Scholar 

  21. Collins P, Chappell SP, Griffith TM, Lewis MJ, Henderson AH. Differences in basal endothelium-derived relaxing factor activity in different artery types. J Cardiovasc Pharmacol 1986;8:1158–1162.

    Google Scholar 

  22. Christie MJ, Lewis MJ. The pig coronary artery is more responsive to endothelium-derived relaxing factor (EDRF) than the rabbit aorta. Br J Pharmacol 1987;91:318.

    Google Scholar 

  23. Angus JA, Cocks TM, Satoh K. 247–1 and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol 1986;88:767–777.

    Google Scholar 

  24. Holtz J, Forstermann U, Pohl U, Giesler M, Bassenge E. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: Effects of cylooxygenase inhibition. J Cardiovasc Pharmacol 1984;6:1161–1169.

    Google Scholar 

  25. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986;250:H1145-H1149.

    Google Scholar 

  26. Pohl U, Busse R, Kuon E, Bassenge E. Pulsatile perfusion stimulates the release of endothelial autocoids. J Appl Cardiol 1986;1:215–235.

    Google Scholar 

  27. Griffith TM, Edwards DH, Davies RL, Harrison TJ, Evans KT. EDRF coordinates the behaviour of vascular resistance vessels. Nature 1987;329:442–445.

    Google Scholar 

  28. Guyton AC, cited in Koch AR. Some mathematical forms of autoregulating models. Circ Res 1964;15(Suppl 1):269–279.

    Google Scholar 

  29. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol (Lond) 1902;28:220–231.

    Google Scholar 

  30. Owen MP, Bevan JA. Acetylcholine induced endothelial-dependent vasodilatation increases as artery diameter decreases in the rabbit ear. Experientia 1985;41:1057–1058.

    Google Scholar 

  31. Zweifach BW. Quantitative studies of microcirculatory structure and function. 1. Analysis of pressure distribution in the terminal vascular bed in cat mesentery. Circ Res 1974;34:843–857.

    Google Scholar 

  32. Kamiya A, Togawa T. Adapative regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol 1980;239:H14-H21.

    Google Scholar 

  33. Takai Y, Kaibuchi K, Matsubara T, Nishizuka Y. Inhibitory action of guanosine 3′,5′-monophosphate on thrombin-induced phosphatidylinositol turnover and protein phosphorylation in human platelets. Biochem Biophys Res Comm 1981;101:61–67.

    Google Scholar 

  34. Schultz K-D, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature 1977;265:750–751.

    Google Scholar 

  35. Ayuma H, Ishikawa M, Sakiyaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986;80: 411–415.

    Google Scholar 

  36. Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987;90:687–692.

    Google Scholar 

  37. Hogan JC, Lewis MJ, Henderson AH. In vivo endothelium-derived relaxing factor inhibition of platelet aggregability. Br J Pharmacol, in press.

  38. Levin RI, Weksler BB, Jaffe EA. The interaction of sodium nitroprusside with human endothelial cells and platelets: Nitroprusside and prostacyclin synergistically inhibit platelet function. Circulation 1982;66:1299–1309.

    Google Scholar 

  39. Rapoport RM, Drazin MB, Mura dF. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 1983;306: 174–176.

    Google Scholar 

  40. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: Stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther 1986;237:893–900.

    Google Scholar 

  41. Forstermann U, Mulsch A, Bohme E, Busse R. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 1986;58:531–538.

    Google Scholar 

  42. Berridge MJ, Irvine RF. Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature (Lond) 1984;312:315–321.

    Google Scholar 

  43. Rapoport RM. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphotidylinositol hydrolysis in rat aorta. Circ Res 1986;58:407–410.

    Google Scholar 

  44. Lewis MJ, Collins P, Lang D. Endothelium-derived relaxing factor and calcium. Trans Biochem Soc, in press.

  45. Henderson AH, Morgan RO, Newby AC. The inhibition of sodium nitroprusside of ADP-induced calcium influx and calcium mobilization in human platelets. J Physiol 1987; 387:89.

    Google Scholar 

  46. Collins P, Griffith TM, Hennderson AH, Lewis MJ. Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: A cyclic guanosine monophosphate-mediated effect. J Physiol (Lond) 1986;381:427–437.

    Google Scholar 

  47. Collins P, Henderson AH, Lang D, Lewis MJ. Endothelium-derived relaxing factor and nitroprusside compared in noradrenaline and K+-contracted aortae of the rabbit and rat. J Physiol (Lond), in press.

  48. Suematsu E, Hirata M, Kuriyama H. Effects of cAMP and cGMP-dependent protein kinases and calmodulin on Ca2+ uptake by highly purified sarcolemmal vesicles of vascular smooth muscle. Biochem Biophys Acta 1984;773:83–90.

    Google Scholar 

  49. Adelstein RS, Hathaway DR. Role of calcium and cyclic adenosine 3′-5′-monophosphate in regulating smooth muscle contraction. Am J Cardiol 1979;44:783–787.

    Google Scholar 

  50. Glagov S, Weisenberg E, Zarins CK, Stankunavivius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371–1375.

    Google Scholar 

  51. Verbeuren TJ, Jordaens F, Zonnekeyn L, Van Hove CE, Coene M-C, Herman AG. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolaemic rabbits. Circ Res 1986;58:552–564.

    Google Scholar 

  52. Sreeharan N, Jayakody RL, Senaratne MPJ, Thomsonn ABR, Kappagoda CT. Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta. Can J Physiol Pharmacol 1986;64:1451–1453.

    Google Scholar 

  53. Chappel SP, Lewis MJ, Henderson AH. Effect of lipid feeding on endothelium-dependent relaxation in rabbit aortic preparations. Cardiovasc Res 1987;21:34–38.

    Google Scholar 

  54. Forstermann U, Mugge A, Alheid U, Haverich A, Frolich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988; 62:185–190.

    Google Scholar 

  55. Van de Voorde J, Leusen I. Endothelium-dependent and independent relaxation of aortic rings from hypertensive rats. Am J Physiol 1986;250:H711-H717.

    Google Scholar 

  56. Shirasaki Y, Su C, Lee TJ-F, Kolm P, Cline WH, Nickols GA. Endothelial modulation of vascular relaxation to nitrovasodilators in ageing and hypertension. J Pharmacol Exp Ther 1986;239:861–866.

    Google Scholar 

  57. Oyama Y, Kawasaki H, Hattori Y, Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 1986;131:75–78.

    Google Scholar 

  58. Griffith TM, Edwards DH, Newby AC, Lewis NJ, Henderson AH. Production of endothelium derived relaxant factor is dependent on oxidative phosphorylation and extracellular calcium. Cardiovasc Res 1986;20:7–12.

    Google Scholar 

  59. De Mey JG, Vanhoutte PM. Anoxia and endothelium-dependent reactivity of the canine femoral artery. J Physiol (Lond) 1983;335:65–74.

    Google Scholar 

  60. Brum JM, Sufan Q, Lane G, Bove A. Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs. Circulation 1984;70:1066–1073.

    Google Scholar 

  61. Ginsberg R, Zera PH. Endothelial relaxant factor in the human epicardial coronary artery (abstract), Circulation 1984;70(Suppl 2):122.

    Google Scholar 

  62. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046–1051.

    Google Scholar 

  63. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 1988;77:43–52.

    Google Scholar 

  64. Griffith TM, Hughes Edwrads D, Lewis MJ, Henderson AH. Ergometrine induced arterial dilatation: An endothelium-mediated effect. J Mol Cell Cardiol 1984; 16:479–482.

    Google Scholar 

  65. Davies MJ, Pepper J, Woolf N, Rowles P. Endothelial integrity in human atherosclerotic coronary arteries. Br Heart J 1988;59:101.

    Google Scholar 

  66. Angelini GD, Bryan AJ, Christie M, Lewis MJ. Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to release endothelium derived relaxing factor (EDRF) (abstract). Br Heart J, in press.

  67. Sax FL, Canon RO, Hanson C, et al. Impaired forearm vasodilator reserve in patients with microvascular angina. N Engl J Med 1987;317:1366–1370.

    Google Scholar 

  68. Editorial. Syndrome X. Lancet 1987;2:1247-1248.

  69. Factor SM, Sonnenblick EH. The pathogenesis of clinical and experimental congestive cardiomyopathies: Recent concepts. Prog Cardiovasc Dis 1985;6:395–420.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Wales College of Medicine, Cardiff, Wales

    Andrew H. Henderson

Authors
  1. Andrew H. Henderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henderson, A.H. Vascular endothelium in ischemic heart disease: Possible role for endothelium-derived relaxing factor. Cardiovasc Drug Ther 3 (Suppl 1), 241–248 (1989). https://doi.org/10.1007/BF00148468

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00148468

Key Words

Search

Navigation